Evidence map›Paper›PMID 33007866›Full record

ArticlePathogens (Basel, Switzerland)2020

A Siderophore Analog of Fimsbactin from

Fabrice Betoudji, Taha Abd El Rahman, Marvin J Miller, Manuka Ghosh, Mario Jacques, Kamal Bouarab, François Malouin

Open access · goldAbstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Fabrice BetoudjiDépartement de Biologie, Faculté des Sciences, Université de Sherbrooke, QC J1K 2R1, Canada.
Taha Abd El RahmanDépartement de Biologie, Faculté des Sciences, Université de Sherbrooke, QC J1K 2R1, Canada.
Marvin J MillerDepartment of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, IN 46556, USA.
Manuka GhoshRosetree Corporate Center, Hsiri Therapeutics, Inc., Media, PA 19063, USA.
Mario JacquesDépartement de Pathologie et Microbiologie, Faculté de Médecine Vétérinaire, Université de Montréal, Saint-Hyacinthe, QC J2S 2M2, Canada.
Kamal BouarabDépartement de Biologie, Faculté des Sciences, Université de Sherbrooke, QC J1K 2R1, Canada.
François MalouinDépartement de Biologie, Faculté des Sciences, Université de Sherbrooke, QC J1K 2R1, Canada.
Université de Sherbrooke · CAHsiri Therapeutics (United States) · USUniversité de Montréal · CAUniversity of Notre Dame · US

Funding

Fonds Québécois de la Recherche sur la Nature et les Technologies 2019-PR-255463
6 · The paper itself

Abstract

Siderophores produced in soil by plant growth-promoting rhizobacteria (PGPRs) play several roles, including nutrient mobilizers and can be useful as plants defense elicitors. We investigated the role of a synthetic mixed ligand bis-catechol-mono-hydroxamate siderophore (SID) that mimics the chemical structure of a natural siderophore, fimsbactin, produced by

Indexed as

AcinetobacterArabidopsis thalianaironPGPRPseudomonas syringaesiderophoressystemic resistance

Identifiers

PMID33007866
PMCPMC7600244
OpenAlexW3091705645

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.